Discover the Best Stocks and Maximize Your Portfolio:
- See what stocks are receiving strong buy ratings from top-rated analysts.
- Filter, analyze, and streamline your search for investment opportunities with TipRanks’ Stock Screener.
Advaxis (ADXS) has provided an update.
Ayala Pharmaceuticals, Inc. finalized a major asset sale on March 25, 2024, leading to the departure of Chief Medical Officer Andres Guttierez. Following this transaction, Roy Golan, the Chief Financial Officer, also agreed to leave the company, with his departure set for June 25, 2024. This strategic move marks a significant reshuffling of Ayala’s executive team amidst its latest corporate developments.
For an in-depth examination of ADXS stock, go to TipRanks’ Stock Analysis page.
